279 related articles for article (PubMed ID: 38361784)
1. HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.
Ma Q; Ye S; Liu H; Zhao Y; Mao Y; Zhang W
Front Oncol; 2024; 14():1320887. PubMed ID: 38361784
[TBL] [Abstract][Full Text] [Related]
2. HMGA2 Modulates the TGFβ/Smad, TGFβ/ERK and Notch Signaling Pathways in Human Lens Epithelial-Mesenchymal Transition.
Hou M; Bao X; Luo F; Chen X; Liu L; Wu M
Curr Mol Med; 2018; 18(2):71-82. PubMed ID: 29974827
[TBL] [Abstract][Full Text] [Related]
3. Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer.
Gong J; Wang Y; Jiang B; Xu B; Hu C
Cancer Manag Res; 2019; 11():4075-4084. PubMed ID: 31118815
[No Abstract] [Full Text] [Related]
4. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
5. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
Thuault S; Tan EJ; Peinado H; Cano A; Heldin CH; Moustakas A
J Biol Chem; 2008 Nov; 283(48):33437-46. PubMed ID: 18832382
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
9. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
Li WJ; Li G; Liu ZW; Chen ZY; Pu R
Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
[TBL] [Abstract][Full Text] [Related]
11. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
12. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
14. Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation.
Qiu F; Liu Q; Xia Y; Jin H; Lin Y; Zhao X
J Exp Clin Cancer Res; 2022 Jan; 41(1):22. PubMed ID: 35031054
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
16. HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.
Watanabe S; Ueda Y; Akaboshi S; Hino Y; Sekita Y; Nakao M
Am J Pathol; 2009 Mar; 174(3):854-68. PubMed ID: 19179606
[TBL] [Abstract][Full Text] [Related]
17. Small interfering-high mobility group A2 attenuates epithelial-mesenchymal transition in thymic cancer cells via the Wnt/β-catenin pathway.
Tan S; Chen J
Oncol Lett; 2021 Aug; 22(2):586. PubMed ID: 34122637
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
Zha L; Zhang J; Tang W; Zhang N; He M; Guo Y; Wang Z
Dig Dis Sci; 2013 Mar; 58(3):724-33. PubMed ID: 23135750
[TBL] [Abstract][Full Text] [Related]
19.
Zhou H; Li L; Xie W; Wu L; Lin Y; He X
Onco Targets Ther; 2020; 13():10489-10498. PubMed ID: 33116628
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.
Thuault S; Valcourt U; Petersen M; Manfioletti G; Heldin CH; Moustakas A
J Cell Biol; 2006 Jul; 174(2):175-83. PubMed ID: 16831886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
